10x Genomics (TXG) Current Assets (2018 - 2026)

10x Genomics' Current Assets history runs 9 years deep, the most recent figure standing at $669.7 million for Q1 2026.

• In Q1 2026, Current Assets rose 15.52% year-over-year to $669.7 million; the TTM figure through Mar 2026 stood at $669.7 million (up 15.52% YoY), while the FY2025 annual figure was $684.5 million, up 17.12% from the prior year.
• Current Assets came in at $669.7 million for Q1 2026 at 10x Genomics, down from $684.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $697.3 million in Q1 2022 to a low of $562.3 million in Q3 2023.
• A 5-year average of $620.3 million and a median of $601.9 million in 2023 frame the typical range for Current Assets.
• Across the five-year window, Current Assets dropped 15.41% in 2022 and gained 17.12% in 2025, its largest moves.
• 10x Genomics' Current Assets stood at $635.0 million in 2022, then slipped by 6.14% to $596.0 million in 2023, then dropped by 1.95% to $584.4 million in 2024, then increased by 17.12% to $684.5 million in 2025, then dropped by 2.15% to $669.7 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $669.7 million, $684.5 million, and $659.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison